Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 162   

Articles published

GSK 1,532.53 -12.97 (-0.84%)
price chart
GlaxoSmithKline boss Walmsley unveils restructuring plan; earnings downgrade ...
It hasn't taken long for new broom Emma Walmsley to make her mark at GlaxoSmithKline PLC (LON:GSK) as the newly installed chief executive used the company's quarterly results to announce a major overhaul of the lumbering drugs titan.
Why I think Woodford was right to dump GlaxoSmithKline plc  AOL UK
Glaxo Looks Beyond the Lab  Bloomberg
GlaxoSmithKline plc 8.4% Potential Upside Indicated by Deutsche Bank
GlaxoSmithKline plc with EPIC/TICKER (LON:GSK) has had its stock rating noted as 'Retains' with the recommendation being set at 'HOLD' this morning by analysts at Deutsche Bank.
GlaxoSmithKline PLC (GSK) Given Neutral Rating at JP Morgan Chase & Co  Week Herald
Banque Pictet & Cie SA Takes Position in GlaxoSmithKline PLC (GSK)  BNB Daily (blog)
Market Fallers: AstraZeneca plc, GKN plc, GlaxoSmithKline plc, Intu Properties PLC
The trading price for AstraZeneca plc with ticker code: LON:AZN has stepped down -15.59% or -797.15 points in today's trading session so far.
Glaxo hoping not to make a right Horlicks of combating generics challenge
GlaxoSmithKline's (LON:GSK) second quarter update will be accompanied by new chief executive Emma Walmsley's plans to revive both the brand and share price.
Market Fallers: GlaxoSmithKline plc, WM Morrison Supermarkets PLC
The trading price for GlaxoSmithKline plc with EPIC code: LON:GSK has dropped -1.68% or -26.73 points throughout the session so far.
GSK confirms plans to sell Horlicks in the UK and cut 320 jobs as it ...
GlaxoSmithKline plc (LON:GSK) has confirmed reports that it plans to sell its Horlicks malt drink brand in the UK that will result in more than 300 job cuts.
GlaxoSmithKline to sell UK Horlicks, cut 320 jobs  MarketWatch
GlaxoSmithkline - Broker downgrade wipes �1.4bn from the value of Europe's ...
A leading investment bank said the challenges to GlaxoSmithKline's (LON:GSK) HIV drug franchise is growing, while rewards from the pill pusher's R&D pipeline are 'distant' as it downgraded its stock recommendation.
GlaxoSmithKline PLC (NYSE:GSK) Stake Reduced by Greylin Investment Mangement Inc.
GlaxoSmithKline PLC logo Greylin Investment Mangement Inc. reduced its position in GlaxoSmithKline PLC (NYSE:GSK) by 1.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission.
GlaxoSmithKline PLC (NYSE:GSK) Stake Maintained by Mathes Company Inc.  BNB Daily (blog)
Analyst Activity – Citigroup Inc. Reiterates Neutral on GlaxoSmithKline PLC ...  Market Exclusive
Better Buy: GlaxoSmithKline plc vs. Bristol-Myers Squibb
Keeping this theme in mind, GlaxoSmithKline plc (NYSE: GSK) and Bristol-Myers Squibb (NYSE: BMY) are two top big pharma stocks that appear to be well positioned to take advantage of this rising tide.
GlaxoSmithKline plc (GSK) Earns “Equal weight” Rating from Barclays PLC
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its “equal weight” rating reaffirmed by Barclays PLC in a research report issued to clients and investors on Thursday.
Duncker Streett & Co. Inc. Increases Stake in GlaxoSmithKline PLC (NYSE:GSK)  BNB Daily (blog)
GlaxoSmithKline plc's (LON:GSK) Equal weight Rating Reaffirmed at ...  StockNewsTimes